News 10 jan 2024 The remarkable chemical-pharmaceutical industry in the canton of Valais For decades, the canton of Valais has cultivated a reputation for excellence in the chemical and pharmaceutical industries, combining innovation ...
News 29 fév 2024 Top Stories from Western Switzerland (February 2024) From significant strides in semiconductor innovation and breakthroughs in medical research to strategic advancements in fintech and medtech secto...
News 26 mai 2023 UCB: "It's difficult to beat Swiss quality - even the Chinese admit as much." UCB UCB is a global biopharmaceutical company based in Belgium. Since 1996, it has invested more than 600 million Swiss francs in a state-of-the-art ...
News 30 jan 2024 Top Stories from Western Switzerland (January 2024) From groundbreaking advancements in agrifood and robotics to strategic economic reforms and pioneering research in space and medicine, discover W...
Actualités 17 oct 2023 Voltiris, Limula et Parithera bénéficient du Start-Up Fund du Biopôle Les start-up vaudoises Voltiris, Limula et Parithera accélèrent le développement de leurs projets innovants grâce à un soutien et un financement ...
News 14 mar 2023 CSEM leads the industrialization of HiFiBiO’s complex microfluidic chips HiFiBiO Therapeutics and CSEM are collaborating to create and produce single-cell microfluidics, which have the potential to revolutionize immuno...
News 17 oct 2023 Voltiris, Limula, and Parithera secure Biopôle’s Start-Up Fund Vaud-based start-ups Voltiris, Limula, and Parithera gain momentum in their innovative ventures as they secure vital funding and support from Bio...
Success stories 25 mai 2023 Merck : “Switzerland offers attractive and stable conditions for international companies.“ Merck Science and technology leader Merck has been in Switzerland for almost a century. Today it has eight sites, including five manufacturing faciliti...
News 06 juil 2022 Clexbio and CSEM join forces to develop the first device to produce vein implants Norwegian start-up Clexbio and CSEM in Neuchâtel have joined forces to develop the world’s first device capable of cultivating human vein tissue ...
Press Release 08 mar 2022 Switzerland Global Enterprise and Switzerland Tourism attract innovative companies to Switzerland As a location for innovation, Switzerland is predestined for the development of new business models with future technologies. The settlement of i...
Communiqués de Presse 06 avr 2022 Switzerland Global Enterprise et Suisse Tourisme invitent des Enterprises d'avant-garde à s'établir en Suisse Berceau de quantité d’innovations, la Suisse est propice au développement de nouveaux modèles d’affaires impliquant les technologies d’avenir. L’...
Success stories 09 juin 2022 La Svizzera offre condizioni interessanti e stabili per le aziende internazionali Merck Il leader scientifico e tecnologico Merck è presente in Svizzera da quasi un secolo. Oggi ha otto sedi, tra cui cinque impianti di produzione, e ...
Comunicati Stampa 10 mar 2022 Switzerland Global Enterprise e Svizzera Turismo invitano aziende innovative in Svizzera La Svizzera, nel suo ruolo di piazza d’innovazione, è ideale per lo sviluppo di nuovi modelli di business con tecnologie del futuro. Un ruolo imp...
Actualités 06 juil 2022 Clexbio et le CSEM s’allient pour développer la première machine à produire des implants veineux La start-up norvégienne Clexbio et le CSEM à Neuchâtel s’allient pour développer la première machine au monde capable de cultiver en laboratoire ...
Medienmitteilungen 08 mar 2022 Switzerland Global Enterprise und Schweiz Tourismus holen innovative Firmen in die Schweiz Die Schweiz ist als Innovationsstandort prädestiniert für die Entwicklung neuer Geschäftsmodelle mit Zukunftstechnologien. Eine wichtige Rolle sp...
ニュース 28 fév 2022 AIスキルの強化で組織力アップへ AI Master Class を提供中 AI、データ、自動化スキル、経営幹部スキルを発展させたい方は、ぜひAI Master Class オンラインプログラムをご活用ください。
News 11 mai 2022 Eurostars grants CEIDOS and Limula EUR 1.14 million for an innovative device In collaboration with Limula, Valais-based CEIDOS has received a grant of EUR 1.14 million from Eurostars to develop a platform dedicated to the ...